Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation

被引：0

作者：

He, Jianming ^{[1
]}

Qiu, Lugui ^{[2
]}

Schmerold, Luke ^{[3
]}

Potluri, Ravi ^{[3
]}

Li, Lin ^{[4
]}

Hu, Peter ^{[5
]}

Nemat, Sepideh ^{[6
]}

Smugar, Steven S. ^{[7
]}

Appiani, Carlos ^{[8
]}

Mehra, Maneesha ^{[9
]}

Richarz, Ute ^{[10
]}

机构：

[1] Janssen, Raritan, NJ USA

[2] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China

[3] Smart Analyst, New York, NY USA

[4] Xian Janssen Pharmaceut Ltd, Beijing, Peoples R China

[5] Janssen R&D, Raritan, NJ USA

[6] Janssen R&D, High Wycombe, Bucks, England

[7] Janssen R&D, Titusville, NJ USA

[8] Janssen R&D, Spring House, PA USA

[9] Janssen Global Serv, Raritan, NJ USA

[10] Janssen Global Serv, Zug, Switzerland

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

Multiple myeloma; multiple myeloma-specific survival; multiple-myeloma specific survival;

D O I：

10.1016/j.clml.2019.09.380

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-054

引用

页码：E229 / E229

页数：1

共 50 条

[21] Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis [J].

Chi-Maw Lin ;

Lih-Chyun Chang ;

Wen-Yi Shau ;

Chi-Ling Chen ;

Chi-Yuan Yao ;

Feng-Ming Tien .

BMC Cancer, 23

[22] Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape [J].

Borgsten, Fredrik ;

Gatopoulou, Xenia ;

Pisini, Marta ;

Tambour, Magnus ;

Schain, Frida ;

Jones, Christina V. ;

Kwok, Kelvin Ho Man ;

Batyrbekova, Nurgul ;

Bjorkholm, Magnus .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) :92-103

[23] High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group [J].

Hus, Iwona ;

Manko, Joanna ;

Jawniak, Dariusz ;

Jurczyszyn, Artur ;

Charlinski, Grzegorz ;

Poniewierska-Jasak, Katarzyna ;

Usnarska-Zubkiewicz, Lidia ;

Sawicki, Mateusz ;

Druzd-Sitek, Agnieszka ;

Swiderska, Alina ;

Kopinska, Anna ;

Grzasko, Norbert ;

Razny, Malgorzata ;

Wedlowska, Aleksandra ;

Perzynski, Aleksander ;

Galazka, Aleksandra ;

Dytfeld, Dominik ;

Kubicki, Tadeusz ;

Rodzaj, Marek ;

Waszczuk-Gajda, Anna ;

Drozd-Sokolowska, Joanna ;

Poglodek, Bartlomiej ;

Pasternak, Anna ;

Dlugosz-Danecka, Monika ;

Szymczyk, Agnieszka ;

Dmoszynska, Anna .

ONCOLOGY LETTERS, 2019, 18 (06) :5811-5820

[24] Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation [J].

Geng, Chuanying ;

Zhou, Huixing ;

Wang, Huijuan ;

Li, Yanchen ;

Leng, Yun ;

Zhang, Zhiyao ;

Jian, Yuan ;

Yang, Guangzhong ;

Chen, Wenming .

BMC CANCER, 2022, 22 (01)

[25] Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation [J].

Ma, Kewa ;

Ye, Jiannan ;

Wang, Lingling ;

Sun, Chao ;

Zhou, Xin .

ONCOTARGETS AND THERAPY, 2021, 14 :2349-2361

[26] Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation [J].

Chuanying Geng ;

Huixing Zhou ;

Huijuan Wang ;

Yanchen Li ;

Yun Leng ;

Zhiyao Zhang ;

Yuan Jian ;

Guangzhong Yang ;

Wenming Chen .

BMC Cancer, 22

[27] Treatment of multiple myeloma patients with autologous stem cell transplantation - a fresh analysis [J].

Wach, Malgorzata ;

Cioch, Maria ;

Hus, Marek ;

Jawniak, Dariusz ;

Legiec, Wojciech ;

Malek, Magdalena ;

Manko, Joanna ;

Walter-Croneck, Adam ;

Wasik-Szczepanek, Ewa ;

Dmoszynska, Anna .

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (02) :248-254

[28] Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell Transplantation [J].

Moreau, Philippe ;

Hulin, Cyrille ;

Facon, Thierry .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) :829-+

[29] Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients [J].

Silvennoinen, Raija ;

Kairisto, Veli ;

Pelliniemi, Tarja-Terttu ;

Putkonen, Mervi ;

Anttila, Pekka ;

Saily, Marjaana ;

Sikio, Anu ;

Opas, Jorma ;

Penttila, Karri ;

Kuittinen, Taru ;

Honkanen, Tuomo ;

Lundan, Tuija ;

Juvonen, Vesa ;

Luukkaala, Tiina ;

Remes, Kari .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) :561-564

[30] Bortezomib in combination with chemotherapy and autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma patients: single-center study results [J].

Sui, Weiwei ;

Zou, Dehui ;

An, Gang ;

Deng, Shuhui ;

Xu, Yan ;

Yi, Shuhua ;

Li, Zengjun ;

Zhao, Yaozhong ;

Qiu, Lugui .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10) :10627-10634

← 1 2 3 4 5 →